To illustrate the proposed simulation approach for the multi-echelon inventory system selection problem, we provide an application through the comparison of the 4 alternatives defined in
Table 3 for the case of the Moroccan pharmaceutical products supply chain in the public sector. The model parameters are based on data provided by the procurement division of the Ministry of health. In the current section, we present an application of the steps of our simulation-based approach. We design the conceptual model of the multi-echelon inventory system alternatives by applying the framework for conceptual modeling presented in
Section 4. We start with an illustration of the simulation model and objectives. After that, we identify the model inputs and outputs based on
Section 4. Then, The model scope and simulation layout are developed for the Moroccan pharmaceutical products supply chain in the public sector using Flexsim software [
34] and following
Table 4 and
Table 5. Finally, we run the experimentation on Flexsim software [
34] and we discuss the simulation outcomes and results.
5.1. Simulation Model and Objectives
The deliveries by the Procurement Division of the Moroccan Ministry of Health are made in a planned manner with generally 4 deliveries per year to the following warehouses: Central Warehouse of Berrechid, Central pharmacy, warehouse of Beausejour, and Warehouse of Derb Ghalef. The four warehouses deliver pharmaceutical products to the 12 regions of Morocco grouped as shown in
Figure 4.
Morocco has adopted a new territorial division. It now has 12 Regions according to Decree No. 2.15.10 of 20 February 2015, fixing the number of regions, their names, their capitals, and the Prefectures and Provinces composing them, published in Official Bulletin No. 6340 of March 5, 2015. The list of the 12 regions is as follows: (1) Tanger-Tétouan-Al Hoceima, (2) Oriental, (3) Fez-Meknès, (4) Rabat- Salé-Kénitra, (5) Beni Mellal -Khnifra, (6) Casablanca-Settat,(7) Marrakesh-Safi,(8) Draa-Tafilalt, (9) Souss-Massa, (10) Guelmim Oued Noun, (11) Laayoune Sakia al Hamra, (12) Dakhla-Oued Eddahab [
42].
The model to be studied in the current section will be a single-product multi-echelon inventory management problem in a two-echelon distribution system as illustrated in
Figure 4. The distribution system structure is composed of two echelons as the following: Echelon 1: The central warehouse and 3 other secondary warehouses. Echelon 2: Regional warehouses, regional pharmacies, provincial pharmacies, and hospital pharmacies in 4 major groups of the 12 regions of Morocco. Following the work of [
15], the 12 Moroccan regions were grouped such that all regions in a group order from the same warehouse and have approximately the same reorder point.
The system is composed of one supplier presenting different pharmaceutical laboratories and suppliers, the central warehouse (CW) of Berrechid, the secondary warehouse (SW1) of Beauséjour, the central pharmacy (SW2), and the secondary warehouse of Derb-Ghalef (SW3) and four major “retailers” that present the four major regions of Morocco. Each node replenishes items from a designated location at the next upstream echelon. When the upstream facility has sufficient inventory, the next location receives the order after a stochastic lead time. Thus, demand is fulfilled at the downstream installations. Patients and basic healthcare facilities are considered willing to wait and demand is back-ordered if it is not fulfilled. The four regions in the downstream stage of the studied supply chain will wait for the demand to be fulfilled if the warehouses of the upstream stage have a stock-out. The regions face external demand with a stochastic arrival time. We assume demand has a stochastic distribution. We assume that the highest echelon (the supplier) has an infinite source of supply. The
inventory control policy is used in all nodes of the system. We recall that the installation stock
ordering policy is an ordering method that consists of ordering a fixed quantity
Q when the inventory level at a certain installation fall below the reorder point
R. In this case, each facility uses its inventory position while in the echelon stock ordering policy, the inventory position of a certain installation is the installation inventory added to all downstream inventory positions [
15].
The objective of this simulation model is to compare the implementation of four different scenarios presenting four multi-echelon inventory system alternatives described in
Table 6. The major preference for the Ministry of Health regarding the decision problem is the level of product availability at the most downstream stages of the supply chain. Thus, we aim in the current section to compare inventory levels at each node of the system to illustrate the product availability at different stages of the supply chain for the four scenarios/alternatives.
5.4. Simulation Outcomes and Discussion
The four simulation experiments were run for 1 year. We simulate 1 year of replenishment and inventory control across the Moroccan pharmaceutical products supply chain stages. Comparing the four multi-echelon inventory system alternatives, we analyze the simulation results.
We present in
Figure 6,
Figure 7,
Figure 8 and
Figure 9 the Content vs. Time of the 4 scenarios and for each node of the multi-echelon distribution inventory system. The content vs. time graphs provided by the Flexsim simulation software allow for depicting the changes in inventory quantities in each facility denoted as “content”, over a period of time (in this case 1 year from October 2022 to October 2023). We provide the Average Content for each node of the system for the four alternatives in
Figure 10. The Content vs. Time illustrates the inventory levels for each node of the supply chain. The Average Content presents the average inventory of the pharmaceutical product considered in the current case study for each installation/node of the multi-echelon inventory system for a certain scenario.
Based on the Content vs. time and average content graphs for the four alternatives and comparing both the installation stock ordering policy and echelon stock ordering policy, the results show that the average inventory level at the downstream stages (the hospitals/healthcare facilities of the 4 major regions) is relatively the same for both policies. The average inventory for the warehouses and secondary warehouses is larger for the echelon stock policy. We can see also that the smaller the values of R, the smaller are inventory amounts at the region’s hospitals and healthcare facilities. In other words, the small values of R related to the installation stock policy led to reducing the level of inventories held in the warehouses.
One advantage of an installation stock policy is that once the reorder points are set, all that is needed to control replenishment is local information. We’ll need the installation inventory position as well as the inventory positions of all downstream installations to apply an echelon stock policy. An alternative is to have information about the initial echelon stock inventory position and be able to monitor final customer demand. In practice, however, determining the echelon stock from these data is often challenging due to different changes in inventory positions, such as damage and obsolescence. This was also the case when dealing with such data provided by the Ministry of Health procurement division.
For the same ordering policy (installation stock policy or Echelon stock policy), and comparing either PA1 with PA2 or PA3 with PA4, it is clear that inventory levels are higher at the most downstream installations (the four major regions) for PA2 and PA4. This is due to the allocation policy of safety stocks to the downstream facilities. On one hand, this will provide a secure level of product availability (products will be near customers and at appropriate amounts). On the other hand, this means added inventory costs at the lower level of the supply chain.
Comparing the four simulated scenarios, and starting with an analysis of PA1 results, we can see that PA1 has the highest average inventory in the upstream facilities (CW, SW1, SW2, and SW3) followed by PA2, PA3, and then PA4. For PA1, this is explained by the calculation of inventories that takes into consideration the echelon inventory which is the installation inventory of the facility added to all downstream stages inventory. Moreover, The safety stock allocation for PA1 was for upstream stages. This implies a high amount of average inventory compared to other alternatives. Thus, inventory holding costs will be the highest for the upstream facilities for PA1, but the ordering costs will be lower since not many orders are placed until April 2023 in the simulation model. The average inventory for the four major regions for PA1 is slightly lower than other alternatives using the installation stock policy. This will have a slight impact on product availability compared to other scenarios PA3 and PA4 that prove a higher level of average inventory at the lowest level of the supply chain.
The simulation provided us with an opportunity to test the four alternatives and compare their performance in terms of product availability and inventory costs. This was done through the outputs regarding inventory levels at different installations of the pharmaceutical supply chain studied. Each scenario gives visibility on the average level of inventory as well as the inventory amount ordered and consumed over time by different actors of the multi-echelon inventory system under study. This will guide the decision makers of the procurement division of the Moroccan pharmaceutical product supply chain to understand the pattern behavior of the inventory dynamics for each scenario and be able to take the right and appropriate decision on which option to choose.
Consequently, if we would like to classify the alternatives PA1, PA2, PA3, and PA4 in terms of either the level of product availability or inventory holding costs, we will end up with the ranking provided in
Table 9 and
Table 10 that provide insights to the decision-makers in the procurement division to choose the scenario that corresponds to their preferences.
Table 9 presents the total average inventory holding costs for the four alternatives. The values were obtained by multiplying the average inventory costs by the holding cost of the product under study.
Table 10 illustrates a ranking of alternatives according to the product availability in the four major regions (R5-6-7, R1-2, R9-10-11-12, and R3-4-8). This table was formed by comparing different average inventory levels in different downstream facilities for the four scenarios simulated.
By analyzing
Table 9, we can see that option PA2 is the highest alternative in terms of average holding costs followed by PA1, PA4, and PA3. We can see in
Table 10 that PA2 and PA4 provide a high level of product availability in the most downstream stages of the pharmaceutical supply chain. According to the procurement division of the Ministry of Health, a high level of product availability is more important for the decision-makers than the inventory-related cost criteria. By considering this preference, we can conclude that the alternative PA4 which is characterized by adopting an installation stock
policy in all supply chain nodes and allocating safety stock in downstream facilities (the four major regions) is the suitable alternative for the case of the Moroccan pharmaceutical products supply chain in the public sector. It provides not only a high level of product availability but implies less holding costs compared to PA2 as both of these options provide the same level of product availability.
The results obtained by the simulation study provide concrete and clear guidelines to the decision makers to choose and select the best scenario that suits their needs and preferences. Different graphs and tables presented in the current section were a clear illustration of the levels of inventories across the whole supply chain. They describe patterns of inventory consumption and supply for 1 year.
The best alternative for the Moroccan pharmaceutical supply chain in the public sector that resulted from the simulation study in the current section was implementing an installation stock
policy with an allocation of safety stocks in downstream stages close to basic healthcare facilities. The same option was proven to be the most appropriate for the supply chain under study in the application of the MCDM-based approach for multi-echelon inventory system selection in a previous work [
29]. Thus, both suggested approaches resulted in the same multi-echelon inventory system alternative and this presents a strong guideline to the decision-makers of the pharmaceutical supply chain to proceed with such an option.
Our paper adds to the existing literature a general simulation-based approach for multi-echelon inventory system selection. By following the suggested approach, decision-makers will have the opportunity to choose and validate the inventory policies that meet their needs in terms of supply chain responsiveness and efficiency. Our research work fits into the existing literature as well by providing guidelines for supply chain managers that can be tested and validated through simulation. Previous studies related to our topic dealt with simulating multi-echelon inventory control policies. Xu et al. [
13] developed a simulation-based optimization model of the multi-echelon inventory system for fresh agricultural items in recent research work. The authors demonstrated through the simulation results that the suggested simulation model can help decision-makers cope with the complexity of the inventory system. Zhang et al. [
14] simulated two inventory strategies for a multi-echelon inventory control model for fresh goods. The research study’s findings, according to the authors, could help managers of supply chains for fresh products make judgments on inventory management and reduce expenses. The application of the simulation-based approach performed in our paper in
Section 5 is a valuable and novel contribution to the multi-echelon inventory management literature in the pharmaceutical products supply chain sector.